comparemela.com

mRNA vaccines developed against the spike glycoprotein of severe acute respiratory syndrome type 2 coronavirus (SARS-CoV-2), displayed remarkable efficiency in combating coronavirus 19 (COVID-19).

Related Keywords

Japan ,Tokyo ,Toshihiro Ito ,Kouji Matsushima ,Hiroyasu Aoki ,Satoshi Ueha ,University Of Tokyo ,Pfizer ,Tokyo University Of Science ,Nara Medical University ,Associate Professor Satoshi Ueha ,Professor Kouji Matsushima ,Tokyo University ,Professor Toshihiro Ito ,Cell Reports ,Associate Professor ,

© 2024 Vimarsana

comparemela.com © 2020. All Rights Reserved.